<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00233090</url>
  </required_header>
  <id_info>
    <org_study_id>GCO #02-0677</org_study_id>
    <secondary_id>H133A020501</secondary_id>
    <nct_id>NCT00233090</nct_id>
  </id_info>
  <brief_title>Post-Traumatic Brain Injury (Post-TBI) Fatigue and Its Treatment</brief_title>
  <official_title>Post-TBI Fatigue and Its Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>U.S. Department of Education</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <brief_summary>
    <textblock>
      Randomized clinical trial of modafinil vs. placebo for treatment of fatigue after TBI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose: The purpose of this study is to examine the efficacy of the drug modafinil as a
      treatment for fatigue post TBI.

      Background: After TBI, fatigue is one of the most common complaints, as documented in our
      work and that of many other researchers. People with TBI experience fatigue that seems to
      them out of proportion to whatever work they are doing or effort they are making. Fatigue
      after TBI is associated with decreased participation in normal activities in the community
      and has been linked to depression.

      Need for Research: Research on use of drugs to treat post-TBI fatigue is inadequate. While
      studies of fatigue in people with other chronic conditions suggest that modafinil helps
      relieve fatigue and has fewer side effects than some other drugs used in treating fatigue,
      the use of modafinil has not yet been tested in people with TBI.

      Current and Future Research Activity: More than 100 men and women volunteers who complain of
      post-TBI fatigue will be randomly assigned to a 4-week period of taking modafinil or a
      placebo. At the beginning and end of the study, the severity of their fatigue and associated
      symptoms (e.g., cognitive function, mood, pain, daytime sleepiness, sleep quality, health
      status) will be assessed, as well as their participation in activities and perceived quality
      of life. It is hypothesized that modafinil will reduce the symptoms of fatigue and will
      increase level of activity and perceived quality of life to a significantly greater extent
      than will the placebo.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient recruitment
  </why_stopped>
  <start_date>July 2005</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fatigue</measure>
    <time_frame>comparison pre and post treatment</time_frame>
    <description>Self-report of fatigue</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive Performance</measure>
    <time_frame>comparison pre and post treatment</time_frame>
    <description>Cognitive performance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mood</measure>
    <time_frame>comparison pre and post treatment</time_frame>
    <description>mood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>comparison pre and post treatment</time_frame>
    <description>pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Quality</measure>
    <time_frame>comparison pre and post treatment</time_frame>
    <description>sleep quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Status</measure>
    <time_frame>comparison pre and post treatment</time_frame>
    <description>health status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participation</measure>
    <time_frame>comparison pre and post treatment</time_frame>
    <description>participation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>comparison pre and post treatment</time_frame>
    <description>quality of life</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Fatigue</condition>
  <arm_group>
    <arm_group_label>Modafinil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>single dose of 200 mg. a day of modafinil for four weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Modafinil</intervention_name>
    <description>single dose of 200 mg. a day of modafinil for four weeks</description>
    <arm_group_label>Modafinil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>daily dose of placebo for four weeks.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Individuals who sustained a TBI with a documented loss of consciousness or evidence of a
        TBI on neuroimaging studies and who are at least 12 months post-injury, who complain of
        fatigue and who have scores of 22 or above on the Barroso Fatigue Scale will be eligible to
        participate in this study. Subjects must not meet criteria for alcohol or substance abuse
        using the Structured Clinical Interview for DSM-IV (SCID) for at least six months prior to
        study enrollment.

        Exclusion Criteria:

        - Diagnosis of chronic neurological disease (including Lyme disease), narcolepsy, current
        infectious disease, chronic fatigue syndrome, fibromyalgia, anemia, hypothyroidism not
        adequately controlled with medication, blood pressure greater 150/100 mm Hg, or clinically
        significant major systemic disease. In addition, individuals taking medications which are
        known to cause fatigue will be excluded from participation in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wayne A Gordon, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029-6574</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2005</study_first_submitted>
  <study_first_submitted_qc>October 3, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2005</study_first_posted>
  <results_first_submitted>August 7, 2013</results_first_submitted>
  <results_first_submitted_qc>March 16, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 15, 2016</results_first_posted>
  <last_update_submitted>March 16, 2016</last_update_submitted>
  <last_update_submitted_qc>March 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fatigue</keyword>
  <keyword>TBI</keyword>
  <keyword>brain injury</keyword>
  <keyword>Modafinil</keyword>
  <keyword>traumatic brain injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Fatigue</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Modafinil</mesh_term>
    <mesh_term>Armodafinil</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Modafinil</title>
          <description>single dose of 200 mg. a day of modafinil for four weeks</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>daily dose of placebo for four weeks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Modafinil</title>
          <description>single dose of 200 mg. a day of modafinil for four weeks</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>daily dose of placebo for four weeks</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52" spread="12"/>
                    <measurement group_id="B2" value="54" spread="13"/>
                    <measurement group_id="B3" value="53" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fatigue</title>
        <description>Self-report of fatigue</description>
        <time_frame>comparison pre and post treatment</time_frame>
        <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
        <group_list>
          <group group_id="O1">
            <title>Modafinil</title>
            <description>single dose of 200 mg. a day of modafinil for four weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>daily dose of placebo for four weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Fatigue</title>
          <description>Self-report of fatigue</description>
          <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cognitive Performance</title>
        <description>Cognitive performance</description>
        <time_frame>comparison pre and post treatment</time_frame>
        <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
        <group_list>
          <group group_id="O1">
            <title>Modafinil</title>
            <description>single dose of 200 mg. a day of modafinil for four weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>daily dose of placebo for four weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Cognitive Performance</title>
          <description>Cognitive performance</description>
          <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mood</title>
        <description>mood</description>
        <time_frame>comparison pre and post treatment</time_frame>
        <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
        <group_list>
          <group group_id="O1">
            <title>Modafinil</title>
            <description>single dose of 200 mg. a day of modafinil for four weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>daily dose of placebo for four weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Mood</title>
          <description>mood</description>
          <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain</title>
        <description>pain</description>
        <time_frame>comparison pre and post treatment</time_frame>
        <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
        <group_list>
          <group group_id="O1">
            <title>Modafinil</title>
            <description>single dose of 200 mg. a day of modafinil for four weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>daily dose of placebo for four weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Pain</title>
          <description>pain</description>
          <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sleep Quality</title>
        <description>sleep quality</description>
        <time_frame>comparison pre and post treatment</time_frame>
        <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
        <group_list>
          <group group_id="O1">
            <title>Modafinil</title>
            <description>single dose of 200 mg. a day of modafinil for four weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>daily dose of placebo for four weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Quality</title>
          <description>sleep quality</description>
          <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health Status</title>
        <description>health status</description>
        <time_frame>comparison pre and post treatment</time_frame>
        <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
        <group_list>
          <group group_id="O1">
            <title>Modafinil</title>
            <description>single dose of 200 mg. a day of modafinil for four weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>daily dose of placebo for four weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Health Status</title>
          <description>health status</description>
          <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participation</title>
        <description>participation</description>
        <time_frame>comparison pre and post treatment</time_frame>
        <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
        <group_list>
          <group group_id="O1">
            <title>Modafinil</title>
            <description>single dose of 200 mg. a day of modafinil for four weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>daily dose of placebo for four weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Participation</title>
          <description>participation</description>
          <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life</title>
        <description>quality of life</description>
        <time_frame>comparison pre and post treatment</time_frame>
        <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
        <group_list>
          <group group_id="O1">
            <title>Modafinil</title>
            <description>single dose of 200 mg. a day of modafinil for four weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>daily dose of placebo for four weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life</title>
          <description>quality of life</description>
          <population>Study terminated due to low enrollment. data was not analyzed and is no longer available for analysis. Data not kept electronically and study records are no longer available.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Modafinil</title>
          <description>single dose of 200 mg. a day of modafinil for four weeks</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>daily dose of placebo for four weeks</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Study was terminated due to insufficient recruitment. Data analysis not available.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Wayne A Gordon, PhD</name_or_title>
      <organization>Icahn School of Medicine at Mount Sinai</organization>
      <phone>212-659-9372</phone>
      <email>wayne.gordon@mssm.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

